Abstract. The forced swimming test (FST) in mice is widely used to predict the antidepressant activity of a drug, but information describing the immobility of female mice is limited. We investigated whether a prior swimming experience affects the immobility duration in a second FST in female mice and whether the test-retest paradigm is a valid screening tool for antidepressants. Female ICR mice were exposed to the FST using two experimental paradigms: a single FST and a double FST in which mice had experienced FST once 24 h prior to the second trail. The initial FST experience reliably prolonged immobility duration in the second FST. The antidepressants imipramine and paroxetine significantly reduced immobility duration in the single FST, but not in the double FST. Scopolamine and the sigma1 (s1) antagonist NE100 administered before the second trial significantly prevented the prolongation of immobility. Neither a 5HT 1A nor a 5HT 2A receptor agonist affected immobility duration. We suggest that the test-retest paradigm in female mice is not adequate for predicting antidepressantlike activity of a drug; the prolongation of immobility in the double FST is modulated through acetylcholine and s1 receptors.
Introduction
In 1993, the U.S. Federal Drug Administration (FDA) encouraged the inclusion of both females and males in clinical trials, but the guidelines for clinical trials in the U.S., Japan, and the EU have rarely emphasized the analysis of drug data for each gender (1) . Even the general considerations for clinical trials issued by the International Conference on Harmonization (2) have not yet appreciated the earnest concern from women who want to know whether the drug they are prescribed has proven effectiveness and safety in females. Anti depressant drugs, which are prescribed over a long period of time to prevent the recurrence of depression, are no exception. The prevalence of mood disorders is higher in females than in males, and the effectiveness of anti depressants differs between genders (3 -5) . Neverthe less, drug development processes for new antidepressant candidates rarely take female animals into consideration.
In experimental psychopharmacology, little attention has been paid to the effect of drugs on female behavior. The forced swimming test (FST) in mice, which was originally conceived by Porsolt (6) , is a wellknown and useful model for preclinical evaluation of the antidepres sant properties of a drug. A review by PetitDemouliere et al. (7) concluded that the FST in mice offers sufficient reliability, predictive validity, and low costs; and virtu ally all clinically used antidepressants reliably shorten the duration of immobility in the FST. Numerous studies have used male mice for the FST, but future preclinical
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screening of new antidepressant candidates should in clude females. The focus on male animals in behavioral analyses of drug effects may be attributable to the com plications that endocrine changes during the estrous cycle create for the analysis of data from female animals. However, David et al. (8) found no difference in the immobility duration between male and female mice, and Bekku et al. (9) demonstrated no significant difference in immobility duration among the four estrous stages in female ICR mice.
Several investigators have observed the prolongation of immobility in male mice (10, 11) ; when mice were forced to swim for 15 min on the first day, followed by a 5 -6min retest 24 h later, the immobility duration was significantly longer than that in the first FST. Although this double FST was originally devised to provide repro ducibility in rats (12) , some investigators have applied the rat FST protocol to mice to ensure the consistency of immobility duration measurements between groups (13 -15). It remains, however, to be determined whether the immobility duration of female mice in the second FST is a valid screening tool for antidepressants. The double FST paradigm may include learning or memory processes not involved in the single FST, and it does allow for the possibility that drug action on learning or memory may be involved in the antidepressantlike effects of a drug. In contrast to Seligman's "learned helplessness" experiments (16) which were based on a behavioral disorder under uncontrollable circumstances that had been previously reinforced using classical con ditioning, Porsolt et al. (6) proposed that an immobile posture following an inescapable situation was closely related to a feeling of despair and they termed this "behavioral despair." When mice were unpredictably put into a cylinder containing water, they manifested vigorous activities such as struggling, climbing, and swimming to escape from the cylinder and then displayed an immobile posture of floating without movement. In the double FST, it appears that this implicit memory, accompanied by an emotional response, may sensitize the animals to the cylinder with water, as it swiftly adopts an immobile posture in the second FST, leading to pro longed immobility. In this context, it would appear that the single FST is related to feeling or mood and that the double FST is related to an unpleasant memory. There is, however, little information about whether a prior exposure to a swimming test prolongs the immobility duration in female mice.
In the present study, we used female ICR mice and compared two experimental paradigms: in one, mice naïve to swimming were subjected to a single FST, and in the other, mice were exposed to the initial FST followed by a second test 24 h later (a double FST). We initially compared the immobility duration between female and male mice or between the single and double FSTs. Then, we confirmed the preexposure time needed to prolong the immobility duration in the second test. To prove the validity of the test-retest paradigm in female mice, we determined the effects of imipramine and paroxetine on the single and double FSTs in female mice. Although antidepressants decreased the prolonged immobility in the second FST in male mice (13, 14, 17 -19) , little information concerning drug effects in female mice is available. We further investigated whether the immobility duration in the double FST involved learning and memory processes, using scopolamine, (+)pentazocine, and NE100 because acetylcholine (ACh) and sigma1 (s1) receptors are crucial in mediating memory deficits and cognitive disorders (20 -24) . To elucidate the participation of 5hydroxytryptamine (HT) neuronal activity in the immobility in female mice, we examined the effects of the 5HT 1A receptor agonist tandospirone and the 5HT 2A receptor agonist (−)-2,5-dimethoxy4iodoamphetamine hydrochloride (DOI) on immobility duration in the two FST paradigms. Because drugs can affect general motor activity and produce a false positive FST result, we determined spontaneous motor activity at the dose of each drug that significantly altered immobility duration.
Materials and Methods

Animals
Albino female ICR mice were purchased from CLEA (Osaka) and were adapted to laboratory conditions for at least 2 weeks prior to the start of the experiment (8 weeks of age). Animals were housed 8 mice per cage and had free access to food and water. The cage floors were covered with wood shavings, and mice were handled once per week while the cages were cleaned. Tempera ture within the vivarium was controlled automatically at 23°C ± 2°C with a 12h light-dark cycle. Experiments were conducted in accordance with the National Insti tutes of Health guidelines and the Guide for Animal Experimentation of Ehime University Graduate School of Medicine.
Forced swimming test
All testing was recorded on videotape. For the single FST, a mouse was placed for 6 min into a glass-polycar bonate cylinder (25cmhigh × 10cmwide) filled to a depth of 12 cm with water maintained at 24°C (25) . Immediately following the water exposure, the animal was removed from the cylinder and dried using a water absorbent pad. For mice that were exposed twice to the FST, on the first day, the mouse was placed into the cylinder filled to a depth of 12 cm with water maintained at 24°C for 15 min (except in experiment 2 using three different immersion times: 5, 10, and 15 min). Immedi ately following the exposure to water, the animal was removed from the cylinder, dried using a waterabsorbent pad, and returned to its home cage. At 24 h after the first test, the mouse was placed for 6 min into the cylinder filled with water at 24°C.
Behavioral testing
Behavior testing was conducted between 0900 and 1200 h. The immobility duration was measured by an observer who was kept unaware of the experimental conditions. During the FST, the observer depressed a key on an event recorder console for as long as the immobile posture occurred. The duration and frequency of immobility were recorded automatically via an inter face and were analyzed by a computer program. In this study we measured the total time spent immobile only during the last 4 min of the testing trial.
To measure general motor activity, test cages (42cm long × 26cmwide × 15cmhigh) were identical to the home cages, except they had a transparent polycarbonate cover with holes for ventilation instead of a wiremesh wall. The test was started immediately after placing a mouse into the test cage and lasted for 5 min. Each test was recorded on videotape. Locomotion and rearing were observed as general motor activities (26) and the duration and frequency of each behavioral element were measured by an observer who was kept unaware of the experimental conditions.
Drug administration
Each drug or vehicle was administered between 0800 and 1000 h, and behavioral testing was carried out 30 or 60 min afterward. Scopolamine hydrobromide (Nacalai Tesque, Inc., Kyoto) and methylscopolamine bromide (Nacalai Tesque) were dissolved in isotonic saline and intraperitoneally injected at the indicated times. Imipra mine hydrochloride (Wako Pure Chemical Industries, Ltd., Tokyo) and paroxetine maleate (Sigma, St. Louis, MO, USA) were dissolved in isotonic saline and injected intraperitoneally 30 min before behavioral testing (27, 28) . The (+)pentazocine (Sigma) was suspended in 0.5% carboxymethylcellulose sodium salt (CMC, Nacalai Tesque) and administered subcutaneously 30 min before behavioral testing (13) . NE100 hydrochloride (kindly supplied by Taisyo Pharmaceuticals Co., Ltd., Tokyo) was dissolved in distilled water and administered orally at 4 doses 30 min before behavioral testing (13) . Tando spirone dihydrogen citrate (kindly supplied by Sumitomo Pharmaceuticals Co., Ltd., Osaka) was dissolved in isotonic saline and administered orally 60 min before behavioral testing (29) . The (−)-2,5-dimethoxy-4-iodo amphetamine hydrochloride (DOI, Sigma) was dissolved in isotonic saline and administered subcutaneously 60 min before behavioral testing (9) .
Experimental design
Seven separate series of experiments were conducted. The first experiment was designed to examine whether preexposure to water altered the immobility duration during the second FST when comparing female with male mice. We used an equal number (n = 16) of each gender and subdivided them into single FST and double FST groups using a 2 × 2 factorial design. The second experiment was conducted to elucidate the preexposure time needed to prolong the immobility time of female mice in the second test. In this test, 32 female mice were randomly assigned to 4 groups of 8 mice each for no preexposure or preexposure to the FST for 5, 10, or 15 min. Based on the results of experiment 2, preexposure time was fixed for 15 min in the following experiments.
In the third experiment, we compared the effectiveness of imipramine and paroxetine at 4 different doses between the single and double FST paradigms in female mice. Fiftysix female mice were randomly assigned to 7 groups of 8 mice each to test the drug effects in the single FST and double FST protocols. In the fourth experiment, female mice were treated with scopolamine or methylscopolamine to examine whether a memory of the FST prolonged the immobility time during the second FST. Because memory consists of 3 different compo nents (memorization, memory retention, and retrieval), we used 3 different injection times: 30 min before the first FST, immediately after the termination of the first FST, and 30 min before the second FST, respectively. For each injection time, 56 female mice were randomly divided to 7 groups of 8 mice each and were injected with saline, scopolamine (0.5, 1, and 2 mg/kg), or methyl scopolamine (0.5, 1, and 2 mg/kg).
The fifth experiment was designed to investigate a possible role of s1 receptors in mediating the prolonged immobility time following preexposure to the FST. We used the s1receptor agonist (+)pentazocine and the s1receptor antagonist NE100, each at four different doses. Sixtyfour female mice were randomly assigned to 8 groups of 8 mice each and treated with (+)pentazocine (vehicle, 1, 2.5, and 5 mg/kg) or NE100 (vehicle, 0.25, 0.5, and 1 mg/kg). In the sixth experiment, we determined whether 5HT 1A or 5HT 2A receptors were involved in the prolonged immobility time induced by two FST experi ences. We treated 56 female mice, randomly assigned to 7 groups of 8 mice each, with the 5HT 1A -selective agonist tandospirone (vehicle, 1, 2.5, and 5 mg/kg) or the 5HT 2A agonist (−)-DOI (vehicle, 0.5, and 1 mg/kg).
In the seventh experiment, we examined general motor activity in 80 female mice, randomly assigned to 10 groups of 8 mice each, after treatment with the dose of scopolamine, imipramine, paroxetine, or NE100 that effectively reduced the immobility time in the FST.
Statistical analyses
All data are expressed as means ± standard error (S.E.). Significant differences among several indepen dent groups were evaluated statistically using analysis of variance (ANOVA) for a completely randomized design and were subsequently confirmed using Tukey's honestly significant difference (HSD) test.
Results
Comparison of immobility duration between male and female mice or between single and double FSTs
ANOVA for a factorial design determined that a significant effect exists between the single and double FTSs (F (1,28) = 50,146, P < 0.01). Multiple comparisons with Tukey's test showed that in both female and male mice, the immobility duration was significantly higher in the double FST than in the single FST (P < 0.01; Table 1 ). There was no significant difference between female and male mice.
The pre-exposure time needed to prolong the immobility duration in the second test
As shown in Table 2 , ANOVA determined that there was a significant difference among the 4 groups (F (3, 28) = 59.553, P < 0.01). Compared with the immobility dura tion in a noexposure group, preexposure to water for 10 or 15 min significantly prolonged the immobility duration in the subsequent FST (P < 0.01). Preexposure for 5 min, however, did not alter the immobility duration compared with that of a single FST. Table 3 describes the effects of the antidepressants imipramine and paroxetine on the immobility time. In the single FST, treatment with 20 mg/kg imipramine or 5 and 10 mg/kg paroxetine significantly decreased the im mobility duration of the mice (F (6,49) = 5.614, P < 0.01). In mice exposed twice to the FST, neither imipramine nor paroxetine significantly affected the immobility duration in any of the treatment groups (F (6, 49) = 0.925, N.S.). In the single FST, female mice were placed for 6 min into a cylinder filled with water. In the double FST, female mice were preexposed to the FST for 15 min, and 24 h after the first test, the second FST for 6 min was performed. Imipra mine and paroxetine were administered intraperitoneally 30 min before the behavioral testing. Each value indicates the mean ± S.E.M. for 8 animals. *P < 0.05, **P < 0.01 vs. the vehicletreated group.
Effects of antidepressants on the immobility duration
Effect of scopolamine on immobility duration in the FST
Scopolamine is an Achreceptor antagonist known to produce an amnesialike state in experimental animals (30, 31) . In the present study, we compared its effect with that of methylscopolamine, which does not cross the bloodbrain barrier, to distinguish between central and peripheral actions. Figure 1 shows the effects of different doses of scopolamine and methylscopolamine on im mobility duration in the double FST. When scopolamine or methylscopolamine was administered 30 min before preexposure to the FST, neither drug showed a signifi cant effect on the immobility duration in the second FST (F (6,49) = 1.444, N.S.) (Fig. 1a) . Similarly, neither scopolamine nor methylscopolamine administered im mediately after the first FST altered the immobility dura tion in the second FST (F (6,49) = 0.913, N.S.) (Fig. 1b) . The immobility duration differed significantly among the groups when the drugs were administrated 30 min before the second FST (F (6,49) = 35.907, P < 0.01). Compared with vehicle treatment, the acute administration of scopolamine significantly shortened the immobility duration in a dosedependent manner (P < 0.01). In contrast, methylscopolamine at all doses failed to alter the immobility duration (Fig. 1c) .
Role of s1 receptors in immobility duration
To elucidate the participation of s1 receptors in the alteration of immobility duration induced by two expo sures to the FST, we used a s1receptor agonist, (+) pentazocine, and a s1receptor antagonist, NE100 (Fig. 2) . Treatment with (+)pentazocine did not signifi cantly affect the immobility duration (F (3, 28) = 0.819, N.S.). However, compared with vehicle alone, all doses of NE100 significantly shortened the immobility dura tion in the second FST (F (3,28) = 30.994, P < 0.01).
Effects of 5-HT 1A and 5-HT 2A receptor agonists on immobility duration
Agonists of 5HT 1A and 5HT 2A receptors have been reported to affect the immobility duration in a single FST (9, 23, 32) . We treated animals with the 5HT 1A receptor Fig. 1 . Effect of scopolamine and methylscopolamine on immobility duration in the double FST. In this experiment, mice were preexposed to the FST for 15 min, and 24 h after the first test, the second FST for 6 min was performed. The drugs were administered at three different timings: A) 30 min before the first FST, B) immediately after the first FST, and C) 30 min before the second FST. White columns show the vehicletreated control, and vertical lines indicate means ± S.E.M. for 8 animals. **P < 0.01, significantly different from the vehicletreated group. Fig. 2 . Effect of (+)pentazocine and NE100 on immobility dura tion in the double FST. Mice were preexposed to the FST for 15 min, and 24 h after the first test, the second FST for 6 min was performed. The (+)pentazocine was administered subcutaneously and NE100 was administered orally 30 min before the second FST. White col umns show the vehicletreated control, and vertical lines indicate means ± S.E.M. for 8 animals. **P < 0.01, significantly different from the corresponding vehicletreated group. agonist tandospirone or the 5HT 2A receptor agonist (−)-DOI and measured their effects on the immobility dura tion (Table 4 ). There was no significant difference in the immobility duration among the treatment groups exposed to a single FST (F (6, 49) = 0.534, N.S.) or among those exposed twice to the test (F (6,49) = 1.008, N.S.).
Effects of drug treatments on general motor activity
As motor activity can be particularly enhanced by drug treatment, creating a false positive FST result, we deter mined the spontaneous motor activity of mice treated with the effective doses of the drugs that significantly altered the immobility duration (Table 5) . According to ANOVA, spontaneous motor activity did not differ significantly between drugtreated and vehicletreated groups based on the frequency of locomotion (F (9,70) = 0.786, N.S.), the duration of locomotion (F (9,70) = 1.886, N.S.), the frequency of rearing behavior (F (9,70) = 1.191, N.S.), or the duration of rearing behavior (F (9,70) = 1.595, N.S.).
Discussion
Our results clearly demonstrate that a prior swimming experience significantly prolongs the immobility dura tion in female ICR mice during a second FST. Consistent with previous reports (10, 11) , this phenomenon was also observed in male mice. Interestingly, prolonged immo bility duration was dependent upon the preexposure time period: a 5min preexposure was not sufficient to alter the immobility duration in a second FST, whereas 10 and 15min preexposure periods significantly prolonged the immobility duration in a second FST. Andreatini and Bacellar (33) reported a poor intraclass Each value indicates the mean ± S.E.M. for 8 animals. ANOVA revealed that there was no significant difference in each item among 10 groups. In the single FST, female mice were placed for 6 min into a cylinder filled with water. In the double FST, female mice were preexposed to the FST for 15 min, and 24 h after the first test, the second FST for 6 min was performed.
Tandospirone was administered orally 60 min before behavioral testing, while (−)-DOI was administered subcutane ously 60 min before behavioral testing. Each value indicates the mean ± S.E.M. ANOVA revealed that there was no significant difference in the duration of immobility among the 7 experimental groups.
correlation coefficient (0.05) in male Swiss mice using a test-retest experimental design with a 1week interval, arguing that the FST lacked the stability and reliability for screening antidepressant drugs. However, a close examination of their data reveals significantly prolonged immobility duration in the second FST, indicative of mice learning to cope with an inescapable situation, as described by West (34) , rather than a lack of stability and reliability. Although the ethological meaning of floating with an immobile posture remains unclear, mice quickly learn that escape from the situation is impossible and apparently cope by saving their energy (34) . During a second FST, mice appear to recall the previous experi ence and immediately adopt an immobile posture.
In the present study, the antidepressants imipramine and paroxetine significantly reduced the immobility duration only in a single FST; the drugs failed to decrease the immobility duration in the second FST trial. This is inconsistent with studies in male mice, where an acute injection of imipramine, desipramine, or fluoxetine, using the same treatment paradigm described here, significantly reduced the immobility duration in the second trial (13, 14, 17 -19) . Thus, there appears to be a different effectiveness of antidepressants between male and female mice. Interestingly, a clinical report also suggested that males responded better to imipramine than women (35) . Because the majority of experiments in male mice have used the single FST paradigm and because antidepressants, including imipramine and paroxetine, decreased immobility duration in these experiments (8, 28, 36) , a single FST in mice may be preferable for predicting the antidepressantlike activity of a candidate drug. In any event, the double FST in female mice is not adequate for predicting the anti depressantlike activity of unknown substances. It re mains unsolved, however, whether chronic treatments with antidepressant drugs are effective in the double FST in female mice.
To investigate the role of learning and memory in the FST response, we injected the amnesic drug scopolamine at different times during the experimental protocol. Scopolamine dosedependently shortened the prolonged immobility duration observed during the second FST only when injected 30 min before the trial. This agrees with previous reports describing decreased immobility duration in male rats administered scopolamine at 30 or 60 min before the second trial (37, 38) . By contrast, scopolamine failed to alter the immobility duration in the second FST when scopolamine was injected at either 30 min before or immediately after the first FST. Thus, our findings suggest that in double FST paradigm scopolamine may not impair the acquisition and reten tion of memory process: namely, the action of scopol amine may be due to an effect on memory retrieval. In the literaturs, however, there is a diversity of reports concerning the mechanism of scopolamine's amnesic effect on learning/memory, which appears to depend on the experimental manipulation employed (e.g., single vs. multiple task, conditioned vs. unconditioned learning, or procedural vs. episodic memory). Our finding, show ing that scopolamine did not affect the retention of memory process, is consistent with previous report that scopolamine at 2 or 2.5 mg/kg when injected immediately after the first FST of mice did not affect the immobility duration in the second FST (10, 39) . In male rats, how ever, De Pablo et al. (40) indicated that when admin istered immediately after the first FST, scopolamine significantly increased the mobility counts (electrical units, not duration time) in the second FST. They showed only the percentage of change in relation to subject's number of impulses during the first 5 min of the first trial, but did not show any base levels in each experiment. Thus, it appears that there exist some methodological implications for the interpretation of the FST. Methyl scopolamine, which does not easily cross the bloodbrain barrier, did not alter the immobility duration at the least effective dose levels of scopolamine, irrespective of injection timing. This suggests that the decrease in the immobility duration following the injection of scopol amine is attributable to its anticholinergic action in the brain.
Increasing evidence has demonstrated that s1 recep tors are involved in learning and memory processes, particularly improvements in memory deficits and cognitive disorders (20 -22) . Interestingly, s1 receptors modulate cholinergic and glutaminergic pathways through calcium channels and display powerful anti amnesic and neuroprotective effects in animal models of cognitive dysfunction (22) . The s1receptor agonists (+)SKF 10047 and (±)pentazocine increased ACh release in the hippocampus and frontal cortex (22) . In contrast, the s1 antagonist NE100 was ineffective by itself, but antagonized the effects elicited by the s1 agonist PRE084 on learning and memory impairment induced by carbon monoxide (41) . Additionally, NE100 did not affect learning impairment induced by scopol amine (42) or dizocilpine (43) in male mice, whereas it reversed the effects of s1 agonists.
While an antagonistic effect of NE100 has been reported repeatedly (e.g., 21, 41), little attention has been paid to its amnesiclike effect. Our findings demonstrate that NE100 dosedependently prevented the prolonga tion of immobility in the second FST, and (+)pentazo cine was ineffective. Thus, NE100 may produce a scopolaminelike amnesic effect and/or may impair memory retrieval of the first FST. Alternatively, the prolongation of immobility during the repeated FST may be mediated through the activation of s1 receptors, although this is not supported by the literature in male mice. For example, in male Swiss OF1 mice, s1receptor agonists such as igmesine and (+)SKF10047, but not the antagonist BD1047, decreased the immobility dura tion in the second FST (14) . The same result was reported in male ddY mice treated with either (+)pentazocine or NE100 (13) . As mentioned by Urani et al. (14) , the immobility duration was 180 ± 4 s during the last 4 min of the first trial and increased significantly to 227 ± 5 s in the second trial performed 24 h later. In the present study, the measured immobility durations in ICR male mice were 185.9 ± 4.1 s in the first trial and 219.5 ± 4.5 s in the second trial, indicating that the immobility duration was increased in the second FST independent of the strain. However, possible gender differences in s1 receptor responses remain to be determined. Interest ingly, bilateral ovariectomy in female mice significantly prolonged the immobility duration (9, 25, 44) , and neurosteroids, which are closely related to sex hormones, modulate s1 receptors (45, 46) . Current evidence indicates that 5HT 1A receptors play an important role in mediating the induction of memory impairment (47) and depression (48) . Serotonin interacts with the cholinergic, glutaminergic, dopaminergic, and GABAnergic systems, and thus the observed behavioral effects of 5HT 1A receptor agonists vary across studies (49, 50) . Nevertheless, the stimulation of 5HT 1A or 5HT 2A receptors is involved in the psychotropic action of antidepressant drugs (51, 52) . In the present study, neither the 5HT 1A receptor agonist tandospirone nor the 5HT 2A receptor agonist (−)-DOI affected the im mobility duration in the FST experiments. Our findings with tandospirone are consistent with previous reports showing that 8OHDPAT, also a 5HT 1A receptor ago nist, did not affect immobility duration of male mice (53, 54) . Both acute and chronic treatment with (−)-DOI dosedependently prevented the prolongation of immo bility induced by ovariectomy (9); however, (−)-DOI failed to reduce immobility time during the second FST in the present study, which is consistent with previous results for a single FST (55) . These findings suggest that a different mechanism may underlie the prolongation of immobility with repeated FSTs.
In the present study, none of the drugs affected the duration or frequency of locomotion and rearing, indicat ing that they did not augment general motor activity in mice. Therefore, we can eliminate the possibility that the antidepressantlike effect of the drugs might have been concealed by a druginduced augmentation of motor behavior.
In conclusion, female mice displayed prolonged immobility duration in a second FST, and antidepres sants failed to show any significant effect on the immo bility duration of female mice exposed twice to the FST. The prolongation of immobility duration was prevented by scopolamine or NE100 administered prior to the second trial. This suggests that ACh and s1 receptors may play a role in the response to the test-retest paradigm. We propose that the test-retest paradigm is inadequate for detecting antidepressantlike activity of a drug, possibly because the repetition of the FST may involve a memory process that cannot be eliminated.
